These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11547738

  • 1. Stable ventricular tachycardia is not a benign rhythm: insights from the AVID registry. Antiarrhythmics versus Implantable Defibrillators.
    Indian Heart J; 2001; 53(3):377. PubMed ID: 11547738
    [No Abstract] [Full Text] [Related]

  • 2. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E.
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A, Epstein AE, Herre JM, Klein RC, Platia EV, Wilkoff B, Ledingham RB, Greene HL, Hallstrom AP, DAVID Investigators.
    Am J Cardiol; 2005 Jun 15; 95(12):1431-5. PubMed ID: 15950565
    [Abstract] [Full Text] [Related]

  • 4. "Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry.
    Raitt MH, Renfroe EG, Epstein AE, McAnulty JH, Mounsey P, Steinberg JS, Lancaster SE, Jadonath RL, Hallstrom AP, Antiarrhythmics Versus Implantable Defibrillators investigators.
    Circulation; 2001 Jan 16; 103(2):244-52. PubMed ID: 11208684
    [Abstract] [Full Text] [Related]

  • 5. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E.
    Ital Heart J Suppl; 2000 Apr 16; 1(4):579-80. PubMed ID: 10832150
    [No Abstract] [Full Text] [Related]

  • 6. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MA, Akiyama T, Baessler C, Anderson JL.
    J Am Coll Cardiol; 1999 Aug 16; 34(2):325-33. PubMed ID: 10440140
    [Abstract] [Full Text] [Related]

  • 7. Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia.
    Clesham GJ, Petch MC.
    N Engl J Med; 1997 Jun 05; 336(23):1676; author reply 1677. PubMed ID: 9173276
    [No Abstract] [Full Text] [Related]

  • 8. Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia.
    Uretsky BF.
    N Engl J Med; 1997 Jun 05; 336(23):1677. PubMed ID: 9173277
    [No Abstract] [Full Text] [Related]

  • 9. In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators.
    Epstein AE, Powell J, Yao Q, Ocampo C, Lancaster S, Rosenberg Y, Cannom DS, Herre JM, Greene HL.
    J Am Coll Cardiol; 1999 Oct 05; 34(4):1111-6. PubMed ID: 10520799
    [Abstract] [Full Text] [Related]

  • 10. Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry.
    Pinski SL, Yao Q, Epstein AE, Lancaster S, Greene HL, Pacifico A, Cook JR, Jadonath R, Marinchak RA.
    Am Heart J; 2000 May 05; 139(5):804-13. PubMed ID: 10783213
    [Abstract] [Full Text] [Related]

  • 11. Treatment of arrhythmias in heart failure.
    O'Callaghan PA, Camm AJ.
    Eur J Heart Fail; 1999 Jun 05; 1(2):133-7. PubMed ID: 10937922
    [No Abstract] [Full Text] [Related]

  • 12. Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports.
    van der Werf C, Wilde AA.
    Europace; 2011 Jan 05; 13(1):11-3. PubMed ID: 20851823
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P, De Ponti R, Uriarte JA, Tondo C, Klersy C, Carbucicchio C, Storti C, Riva S, Longobardi M.
    Eur Heart J; 2002 Mar 05; 23(5):414-24. PubMed ID: 11846499
    [Abstract] [Full Text] [Related]

  • 17. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ, Al-Khatib SM.
    Am Heart J; 2004 May 05; 147(5):790-1. PubMed ID: 15131532
    [No Abstract] [Full Text] [Related]

  • 18. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):616-7. PubMed ID: 19660691
    [No Abstract] [Full Text] [Related]

  • 19. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, Eldar M, Hammill SC, Friedman PA.
    J Cardiovasc Electrophysiol; 2004 Jun 11; 15(6):658-64. PubMed ID: 15175060
    [Abstract] [Full Text] [Related]

  • 20. Management of ventricular arrhythmias.
    Aronow WS.
    Compr Ther; 2008 Jun 11; 34(2):89-99. PubMed ID: 18833785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.